Cleveland Clinic

Type

CVC

Status

Active

Location

Cleveland, United States

Total investments

16

Average round size

18M

Portfolio companies

13

Rounds per year

0.16

Lead investments

3

Follow on index

0.19

Exits

3

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsWellnessMedical DeviceMedicalPersonal HealthNeurosciencePharmaceuticalTherapeutics

Summary

In 1921 was created Cleveland Clinic, which is appeared as Corporate Investor. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Cleveland.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Cleveland Clinic, startups are often financed by Venrock, UPMC, Threshold. The meaningful sponsors for the fund in investment in the same round are MemorialCare Innovation Fund, JumpStart Inc., Atrium Health. In the next rounds fund is usually obtained by Wellcome Trust, Venrock, U.S. Venture Partners (USVP).

Among the most popular portfolio startups of the fund, we may highlight SironRX Therapeutics, Hemex Health, Xealth. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Information Technology, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

Speaking about the real fund results, this Corporate Investor is 9 percentage points more often commits exit comparing to other organizations. This Cleveland Clinic works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2011. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2014.

This organization was formed by George Washington Crile, William Edgar. The overall number of key employees were 6.

Show more

Investor highlights

Industry focus
MedtechBiotech/Life SciencesHealthcare

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
16
Lead investments
3
Exits
3
Rounds per year
0.16
Follow on index
0.19
Investments by industry
  • Health Care (12)
  • Therapeutics (8)
  • Biotechnology (5)
  • Medical (5)
  • Medical Device (4)
  • Show 16 more
Investments by region
  • United States (16)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
153K
Group Appearance index
0.94
Avg. company exit year
4
Avg. multiplicator
0.03

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Enspire DBS Therapy 01 Aug 2023 Health Care, Medical, Therapeutics Early Stage Venture 17M United States, Ohio, Cleveland
Neuro Therapia 22 Sep 2020 Neuroscience, Pharmaceutical, Therapeutics Early Stage Venture 8M United States, Ohio, Illinois
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.